PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
HIVE vs. BTBT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between HIVE and BTBT is 0.64, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.6

Performance

HIVE vs. BTBT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in HIVE Blockchain Technologies Ltd (HIVE) and Bit Digital, Inc. (BTBT). The values are adjusted to include any dividend payments, if applicable.

-20.00%0.00%20.00%40.00%60.00%AugustSeptemberOctoberNovemberDecember2025
-3.41%
0.30%
HIVE
BTBT

Key characteristics

Sharpe Ratio

HIVE:

-0.33

BTBT:

-0.09

Sortino Ratio

HIVE:

0.07

BTBT:

0.76

Omega Ratio

HIVE:

1.01

BTBT:

1.08

Calmar Ratio

HIVE:

-0.32

BTBT:

-0.11

Martin Ratio

HIVE:

-0.97

BTBT:

-0.40

Ulcer Index

HIVE:

29.89%

BTBT:

26.27%

Daily Std Dev

HIVE:

87.91%

BTBT:

114.00%

Max Drawdown

HIVE:

-97.72%

BTBT:

-98.16%

Current Drawdown

HIVE:

-88.37%

BTBT:

-88.52%

Fundamentals

Market Cap

HIVE:

$402.61M

BTBT:

$515.79M

EPS

HIVE:

-$0.13

BTBT:

-$0.03

Total Revenue (TTM)

HIVE:

$91.61M

BTBT:

$81.95M

Gross Profit (TTM)

HIVE:

-$1.78M

BTBT:

$28.31M

EBITDA (TTM)

HIVE:

$43.68M

BTBT:

$60.78M

Returns By Period

In the year-to-date period, HIVE achieves a 9.47% return, which is significantly lower than BTBT's 14.68% return.


HIVE

YTD

9.47%

1M

-22.77%

6M

-3.41%

1Y

-25.71%

5Y*

47.74%

10Y*

N/A

BTBT

YTD

14.68%

1M

-25.83%

6M

0.30%

1Y

-3.45%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

HIVE vs. BTBT — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HIVE
The Risk-Adjusted Performance Rank of HIVE is 3131
Overall Rank
The Sharpe Ratio Rank of HIVE is 3030
Sharpe Ratio Rank
The Sortino Ratio Rank of HIVE is 3636
Sortino Ratio Rank
The Omega Ratio Rank of HIVE is 3636
Omega Ratio Rank
The Calmar Ratio Rank of HIVE is 2828
Calmar Ratio Rank
The Martin Ratio Rank of HIVE is 2626
Martin Ratio Rank

BTBT
The Risk-Adjusted Performance Rank of BTBT is 4646
Overall Rank
The Sharpe Ratio Rank of BTBT is 4343
Sharpe Ratio Rank
The Sortino Ratio Rank of BTBT is 5555
Sortino Ratio Rank
The Omega Ratio Rank of BTBT is 5050
Omega Ratio Rank
The Calmar Ratio Rank of BTBT is 4141
Calmar Ratio Rank
The Martin Ratio Rank of BTBT is 4040
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

HIVE vs. BTBT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for HIVE Blockchain Technologies Ltd (HIVE) and Bit Digital, Inc. (BTBT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for HIVE, currently valued at -0.33, compared to the broader market-4.00-2.000.002.00-0.33-0.09
The chart of Sortino ratio for HIVE, currently valued at 0.07, compared to the broader market-4.00-2.000.002.004.000.070.76
The chart of Omega ratio for HIVE, currently valued at 1.01, compared to the broader market0.501.001.502.001.011.08
The chart of Calmar ratio for HIVE, currently valued at -0.32, compared to the broader market0.002.004.006.00-0.32-0.11
The chart of Martin ratio for HIVE, currently valued at -0.97, compared to the broader market-10.000.0010.0020.00-0.97-0.40
HIVE
BTBT

The current HIVE Sharpe Ratio is -0.33, which is lower than the BTBT Sharpe Ratio of -0.09. The chart below compares the historical Sharpe Ratios of HIVE and BTBT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.50AugustSeptemberOctoberNovemberDecember2025
-0.33
-0.09
HIVE
BTBT

Dividends

HIVE vs. BTBT - Dividend Comparison

Neither HIVE nor BTBT has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

HIVE vs. BTBT - Drawdown Comparison

The maximum HIVE drawdown since its inception was -97.72%, roughly equal to the maximum BTBT drawdown of -98.16%. Use the drawdown chart below to compare losses from any high point for HIVE and BTBT. For additional features, visit the drawdowns tool.


-92.00%-90.00%-88.00%-86.00%-84.00%-82.00%-80.00%AugustSeptemberOctoberNovemberDecember2025
-88.37%
-88.52%
HIVE
BTBT

Volatility

HIVE vs. BTBT - Volatility Comparison

The current volatility for HIVE Blockchain Technologies Ltd (HIVE) is 22.52%, while Bit Digital, Inc. (BTBT) has a volatility of 30.80%. This indicates that HIVE experiences smaller price fluctuations and is considered to be less risky than BTBT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


15.00%20.00%25.00%30.00%35.00%40.00%45.00%50.00%AugustSeptemberOctoberNovemberDecember2025
22.52%
30.80%
HIVE
BTBT

Financials

HIVE vs. BTBT - Financials Comparison

This section allows you to compare key financial metrics between HIVE Blockchain Technologies Ltd and Bit Digital, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab